1. Congiu, Chiara, Minelli, Alessandra, Bonvicini, Cristian, Segala, Matilde, Gennarelli, Massimo. 2014. The role of the potassium channel gene KCNK2 in major depressive disorder. In Psychiatry research, 225, 489-92. doi:10.1016/j.psychres.2014.11.061. https://pubmed.ncbi.nlm.nih.gov/25535009/
2. Wang, Jing, Li, Jiaqiong, Cheng, Dan, Li, Xiang, Dong, Zigang. 2023. miR-132-3p promotes heat stimulation-induced esophageal squamous cell carcinoma tumorigenesis by targeting KCNK2. In Molecular carcinogenesis, 62, 583-597. doi:10.1002/mc.23504. https://pubmed.ncbi.nlm.nih.gov/37014157/
3. Liou, Ying-Jay, Chen, Tai-Jui, Tsai, Shih-Jen, Cheng, Chih-Ya, Hong, Chen-Jee. . Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. In Pharmacogenetics and genomics, 19, 735-41. doi:10.1097/FPC.0b013e32832cbe61. https://pubmed.ncbi.nlm.nih.gov/19741570/
4. Lin, Xu, Wu, Jing-Fang, Wang, Dong-Mei, Zhang, Wen-Jing, Xue, Gang. 2020. The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment. In Journal of Cancer, 11, 5162-5176. doi:10.7150/jca.45604. https://pubmed.ncbi.nlm.nih.gov/32742463/
5. Sullivan, Kyle A, Vitko, Iuliia, Blair, Kathryn, Kapur, Jaideep, Perez-Reyes, Edward. 2023. Drug-Inducible Gene Therapy Effectively Reduces Spontaneous Seizures in Kindled Rats but Creates Off-Target Side Effects in Inhibitory Neurons. In International journal of molecular sciences, 24, . doi:10.3390/ijms241411347. https://pubmed.ncbi.nlm.nih.gov/37511107/
6. Li, Wen-Chao, Xiong, Zhi-Yong, Huang, Pin-Zhu, Ren, Jie, Hu, Kun-Peng. 2019. KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma. In Aging, 11, 8169-8182. doi:10.18632/aging.102311. https://pubmed.ncbi.nlm.nih.gov/31581133/
智鼠故事 
